ST Pharm Co.Ltd (237690) — Cash Flow-to-Debt Ratio
ST Pharm Co.Ltd (237690) has a Cash Flow-to-Debt Ratio of -0.11x as of December 2025, meaning its operating cash flow of ₩-21.16 Billion could theoretically repay 0% of its total liabilities (₩189.56 Billion) in one year. See 237690 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ST Pharm Co.Ltd Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for ST Pharm Co.Ltd across 11 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of ST Pharm Co.Ltd.
Annual Cash Flow-to-Debt Ratio for ST Pharm Co.Ltd (2015–2025)
Year-by-year debt coverage analysis for ST Pharm Co.Ltd. Check ST Pharm Co.Ltd (237690) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | ₩13.99 Billion | ₩189.56 Billion | ▼ -85.2% |
| 2024 | 0.50x | ₩109.45 Billion | ₩218.88 Billion | ▲ +11012.0% |
| 2023 | 0.00x | ₩1.30 Billion | ₩288.53 Billion | ▼ -85.1% |
| 2022 | 0.03x | ₩7.03 Billion | ₩233.02 Billion | ▼ -27.1% |
| 2021 | 0.04x | ₩7.27 Billion | ₩175.59 Billion | ▲ +129.7% |
| 2020 | -0.14x | ₩-20.93 Billion | ₩150.24 Billion | ▲ +81.7% |
| 2019 | -0.76x | ₩-30.52 Billion | ₩40.12 Billion | ▼ -198.4% |
| 2018 | 0.77x | ₩10.77 Billion | ₩13.94 Billion | ▼ -56.8% |
| 2017 | 1.79x | ₩54.44 Billion | ₩30.42 Billion | ▲ +92.2% |
| 2016 | 0.93x | ₩50.78 Billion | ₩54.53 Billion | ▲ +173.0% |
| 2015 | 0.34x | ₩35.82 Billion | ₩105.04 Billion | — |